Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical

Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical

Rong Dong,1 Youyou Yan,2 Xiaokang Zeng,3 Nengming Lin,1,2 Biqin Tan1 1Department of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, P...

Full description

Bibliographic Details
Main Authors: Dong R, Yan Y, Zeng X, Lin N, Tan B
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Drug Design, Development and Therapy
Subjects:
ibrutinib
cardiotoxicity
btk inhibitors
atrial fibrillation
cardio-oncology
Online Access:https://www.dovepress.com/ibrutinib-associated-cardiotoxicity-from-the-pharmaceutical-to-the-cli-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/ibrutinib-associated-cardiotoxicity-from-the-pharmaceutical-to-the-cli-peer-reviewed-fulltext-article-DDDT

Similar Items